RAPT Therapeutics Dirección
Dirección controles de criterios 2/4
El CEO de RAPT Therapeutics es Brian Wong , nombrado en Aug 2015, tiene una permanencia de 9.25 años. compensación anual total es $6.59M, compuesta por 9.2% salario y 90.8% primas, incluidas acciones y opciones de la empresa. posee directamente un 1.41% de las acciones de la empresa, por valor de $527.10K. La antigüedad media del equipo directivo y de la junta directiva es de 4.8 años y 7.5 años, respectivamente.
Información clave
Brian Wong
Chief Executive Officer (CEO)
US$6.6m
Compensación total
| Porcentaje del salario del CEO | 9.2% |
| Permanencia del CEO | 9.3yrs |
| Participación del CEO | 1.4% |
| Permanencia media de la dirección | 4.8yrs |
| Promedio de permanencia en la Junta Directiva | 7.5yrs |
Actualizaciones recientes de la dirección
Recent updates
Can RAPT Therapeutics (NASDAQ:RAPT) Afford To Invest In Growth?
Nov 10
RAPT: CCR4 Inhibition Presses On For Now With Oncology Focus
Jul 24Companies Like RAPT Therapeutics (NASDAQ:RAPT) Could Be Quite Risky
Jun 13RAPT Therapeutics: Dip Following FDA Clinical Hold Creates Asymmetric Opportunity
May 20Is RAPT Therapeutics (NASDAQ:RAPT) In A Good Position To Invest In Growth?
Feb 21We Think RAPT Therapeutics (NASDAQ:RAPT) Can Afford To Drive Business Growth
Sep 12We Think RAPT Therapeutics (NASDAQ:RAPT) Can Afford To Drive Business Growth
May 10We're Hopeful That RAPT Therapeutics (NASDAQ:RAPT) Will Use Its Cash Wisely
Feb 07We're Hopeful That RAPT Therapeutics (NASDAQ:RAPT) Will Use Its Cash Wisely
Oct 12RAPT Therapeutics (NASDAQ:RAPT) Is In A Good Position To Deliver On Growth Plans
Jan 25RAPT Therapeutics (NASDAQ:RAPT) Is In A Good Position To Deliver On Growth Plans
Oct 15RAPT Therapeutics (RAPT) skyrockets 100% on positive RPT193 data in early-stage atopic dermatitis study
Jun 14RAPT Therapeutics (NASDAQ:RAPT) Is In A Good Position To Deliver On Growth Plans
Jun 08Should You Take Comfort From Insider Transactions At RAPT Therapeutics, Inc. (NASDAQ:RAPT)?
Mar 15We Think RAPT Therapeutics (NASDAQ:RAPT) Can Easily Afford To Drive Business Growth
Feb 15
RAPT Therapeutics' (NASDAQ:RAPT) Stock Price Has Reduced 56% In The Past Year
Jan 18RAPT Therapeutics: Interesting Asset, But Doubtful History And Bad Market Reaction
Jan 08Here's What RAPT Therapeutics, Inc.'s (NASDAQ:RAPT) Shareholder Ownership Structure Looks Like
Dec 21The Independent Chairman of the Board of RAPT Therapeutics, Inc. (NASDAQ:RAPT), William Rieflin, Just Bought 12% More Shares
Nov 23Earnings Beat: RAPT Therapeutics, Inc. (NASDAQ:RAPT) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts
Nov 19Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$107m |
| Jun 30 2024 | n/a | n/a | -US$120m |
| Mar 31 2024 | n/a | n/a | -US$118m |
| Dec 31 2023 | US$7m | US$605k | -US$117m |
| Sep 30 2023 | n/a | n/a | -US$109m |
| Jun 30 2023 | n/a | n/a | -US$99m |
| Mar 31 2023 | n/a | n/a | -US$93m |
| Dec 31 2022 | US$5m | US$580k | -US$84m |
| Sep 30 2022 | n/a | n/a | -US$79m |
| Jun 30 2022 | n/a | n/a | -US$76m |
| Mar 31 2022 | n/a | n/a | -US$73m |
| Dec 31 2021 | US$3m | US$540k | -US$69m |
| Sep 30 2021 | n/a | n/a | -US$64m |
| Jun 30 2021 | n/a | n/a | -US$60m |
| Mar 31 2021 | n/a | n/a | -US$56m |
| Dec 31 2020 | US$4m | US$500k | -US$53m |
| Sep 30 2020 | n/a | n/a | -US$53m |
| Jun 30 2020 | n/a | n/a | -US$49m |
| Mar 31 2020 | n/a | n/a | -US$47m |
| Dec 31 2019 | US$2m | US$447k | -US$43m |
| Sep 30 2019 | n/a | n/a | -US$39m |
| Jun 30 2019 | n/a | n/a | -US$40m |
| Mar 31 2019 | n/a | n/a | -US$37m |
| Dec 31 2018 | US$1m | US$425k | -US$36m |
Compensación vs. Mercado: La compensación total de Brian($USD6.59M) está por encima de la media de empresas de tamaño similar en el mercado US ($USD652.28K).
Compensación vs. Ingresos: La compensación de Brian ha aumentado mientras la empresa no es rentable.
CEO
Brian Wong (52 yo)
9.3yrs
Permanencia
US$6,591,617
Compensación
Dr. Brian Russell Wong, M.D., Ph.D. serves as Venture Partner at The Column Group, LLC since joining the firm in 2022. He has been Chief Executive Officer and Director at RAPT Therapeutics, Inc. since Augu...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| CEO, President & Director | 9.3yrs | US$6.59m | 1.41% $ 527.1k | |
| CFO, Principal Accounting Officer & Secretary | 4.9yrs | US$2.18m | 0.034% $ 12.6k | |
| Chief Medical Officer | 9.5yrs | US$1.90m | 0.045% $ 16.8k | |
| Vice President of Technology | no data | sin datos | sin datos | |
| Chief Scientific Officer | 5.4yrs | US$1.48m | 0.074% $ 27.6k | |
| General Counsel | 1.8yrs | sin datos | sin datos | |
| Chief Human Resources Officer | 2.5yrs | sin datos | sin datos | |
| Senior Vice President of Quantitative & Computational Biology | 4.7yrs | sin datos | sin datos | |
| Senior Vice President of Drug Discovery & Preclinical Development | 5.8yrs | sin datos | sin datos | |
| Senior Vice President of Regulatory Affairs & Quality Assurance | 2.2yrs | sin datos | sin datos | |
| Senior Vice President of Technical Operations | less than a year | sin datos | sin datos |
4.8yrs
Permanencia media
57.5yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de RAPT se considera experimentado (4.8 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| CEO, President & Director | 9.3yrs | US$6.59m | 1.41% $ 527.1k | |
| Independent Chairman of the Board | 9.5yrs | US$300.28k | 0.27% $ 101.4k | |
| Independent Director | 4.9yrs | US$277.78k | 0% $ 0 | |
| Member of Scientific Advisory Board | 7.5yrs | sin datos | sin datos | |
| Member of Scientific Advisory Board | 7.5yrs | sin datos | sin datos | |
| Chairman of Scientific Advisory Board | no data | sin datos | sin datos | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos | |
| Member of Scientific Advisory Board | 7.2yrs | sin datos | sin datos | |
| Member of Scientific Advisory Board | 5.3yrs | sin datos | sin datos | |
| Independent Director | 6.8yrs | US$267.78k | 0% $ 0 | |
| Independent Director | 7.9yrs | US$260.78k | 0% $ 0 | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos |
7.5yrs
Permanencia media
65yo
Promedio de edad
Junta con experiencia: La junta directiva de RAPT se considera experimentada (7.5 años de antigüedad promedio).